Objective
The enforcement of the new Medical Device and HTA Regulations represents a disruptive change for the industry. On the one hand, companies will be asked to deal with new standards for generating clinical evidence and with the fact that assessments will no longer be the responsibility of each country, but rather centralized at the EU level. On the other, digitalization and the use of new technologies are increasingly advanced, and are unpredictably changing the medtech landscape. To confront these challenges and remain competitive, companies must modernize, radically overhaul their organizational structure and acquire new managerial skills.
The course Value-Based Medtech aims to discuss the drivers of changes and how to successfully respond to new challenges to keep competing in an unstable, unpredictable future. What are the immediate consequences of the new European Regulations? How is the HTA of medical devices evolving in Europe? Does it incorporate environmental impact? What evidence needs to be generated? How, when and by whom should it be evaluated? Will digital technologies (mHealth) be evaluated with the same methods and processes as medical devices? Will the methods of purchasing medical devices change (innovation procurement)? Will reimbursement policies include innovative formulas such as bundled payment? These are some of the questions you will answer by attending the course
This course is for professionals and companies who wish to transform the current context of change into opportunities for growth and development. More specifically, the course is open to health-tech developers and manufacturers, end users, payers, policymakers, patient associations and scientific societies. In order to fully profit from the course, it is advisable to have at least few years of work experience.
Program Counseling
To help you decide whether the contents of the course will meet your expectations and choose the best education options for your profile and objectives, you can contact one of the course’s academic counsellor to discuss the details.
Contact Patrizia Trivellato:patrizia.trivellato@sdabocconi.it
This 3.5-day program (28 equivalent hours) consists of 4 modules, during which participants will delve into the following topics:
1. The Context
2. Evidence Generation and Evaluation
3. Anticipating the "Business Case"
4. Frontier Health Policies to Manage Innovation
Download the brochure to find out more about the expected learning outcomes, the learning model and the Faculty of the course.
Advantages for Participants
Advantages fot the Company
Digital Badges
The digital badges are an innovative and immediate way to share your achievements. They are verifiable and associated with an individual user. They allow you to update your network of contacts by highlighting the different steps reached in your SDA Bocconi journey.
Certificate of Partecipation
The certificate – presented in both print and digital forms – is a useful way to enhance your CV and portfolio of educational experiences. It is granted to participants who have attended at least 80%.
Calendar
The program lasts 3,5 days (28 hours total equivalent).
13 - 19 nov 2023
9:00 am - 6:00 pm
20 - 22 nov 2023
9:00 am - 6:00 pm
23 nov - 1 dic 2023
9:00 am - 6:00 pm
ON CAMPUS
Module
ONLINE ASYNCHRONOUS
Module
Program Location
On-campus training will take place at:
Bocconi School of Management: Via Sarfatti 10, 20136 Milan (Italy)
Fee
€ 3.500 (+ VAT) fee includes educational materials and working lunches, but not VAT. A maximum number of participants is pre-determined. You can reserve and register online on the program’s web page.
Special Payment Terms
For further information and details on discounts, please refer to: www.sdabocconi.it/special-payment-terms
Early Bird
A 10% reduction on the program feeis offered to applications sent in by 3rd of August 2023
Apply ASAP
You can apply for the Program until the day before it is due to start. For organizational reasons, we encourage you to complete your registration process 10 days before the Program begins.
“New regulatory frameworks, changing competitive environment and evolving health needs: these are some of the most compelling challenges that stakeholders in the medical-device sector have to face. The course will explore the conditions and tools that can make the difference for succeeding in a rapidly evolving environment, bringing together solid experience in the sector both from the faculty and from international key opinion leaders.”
“The medical-device sector is experiencing continuous and rapid development. Keeping pace with advances in this complex ecosystem is essential to fostering innovation and, ultimately, improving patients’ health. The course will tackle the most urgent issues in this ever-changing environment, and will be an opportunity to share points of view and hands-on experience in an international context.”
Il corso fornisce ai professionisti del market access e del marketing, della medica e del regolatorio una panoramica più chiara del meccanismo che sottende i modelli di valutazione economica.
Comprendere le opportunità e le criticità collegate alla produzione di evidenze real-world in campo farmaceutico, per leggerle, gestirle e comunicarle al meglio.
Conoscere i principali ambiti di applicazione delle preferenze dei pazienti in sanità, con un focus sui metodi più diffusi per la valutazione delle tecnologie.
